Artivion | CRY - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 2.94M 2026-03
Accuray USD 100K 1000 2024-09
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Edwards Lifesciences USD 577M 3.7M 2026-03
Inogen USD 23K 0 2023-12
Integra LifeSciences USD 77.78M 39K 2026-06
J&J USD 2.41B 1.35M 2026-03
Mesa Laboratories USD 349.53M 3.53M 2024-09
Orthofix International USD 39.83M 315K 2025-12
Pfizer USD 5.7B 0 2026-06
ResMed USD 145.06M 45.78M 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 19K 2026-06
Trinity Biotech USD 386.76M 1.57M 2025-12